U.S. markets close in 5 hours 29 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9697+0.0297 (+1.01%)
As of 10:29AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/14/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.91
52-Week Change 3-28.81%
S&P500 52-Week Change 341.30%
52 Week High 38.9600
52 Week Low 32.0800
50-Day Moving Average 32.7076
200-Day Moving Average 33.2461

Share Statistics

Avg Vol (3 month) 3530.17k
Avg Vol (10 day) 31.74M
Shares Outstanding 534.13M
Implied Shares Outstanding 6N/A
Float 21.66M
% Held by Insiders 118.01%
% Held by Institutions 167.83%
Shares Short (Apr 29, 2021) 41.02M
Short Ratio (Apr 29, 2021) 41.97
Short % of Float (Apr 29, 2021) 43.80%
Short % of Shares Outstanding (Apr 29, 2021) 42.97%
Shares Short (prior month Mar 30, 2021) 4769.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-5,150.82%

Management Effectiveness

Return on Assets (ttm)-36.06%
Return on Equity (ttm)-109.21%

Income Statement

Revenue (ttm)1.34M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-93.90%
Gross Profit (ttm)2.3M
Net Income Avi to Common (ttm)-70.97M
Diluted EPS (ttm)-2.2170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.43M
Total Cash Per Share (mrq)1.21
Total Debt (mrq)44.96M
Total Debt/Equity (mrq)92.83
Current Ratio (mrq)3.30
Book Value Per Share (mrq)1.42

Cash Flow Statement

Operating Cash Flow (ttm)-57.77M
Levered Free Cash Flow (ttm)-30.37M